Fulgent Genetics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FLGT research report →
Companywww.fulgentgenetics.com
Fulgent Genetics, Inc. , together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests.
- CEO
- Ming Hsieh
- IPO
- 2016
- Employees
- 1,313
- HQ
- El Monte, CA, US
Price Chart
Valuation
- Market Cap
- $466.05M
- P/E
- -6.87
- P/S
- 1.45
- P/B
- 0.48
- EV/EBITDA
- -6.74
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.08%
- Op Margin
- -33.07%
- Net Margin
- -23.04%
- ROE
- -6.70%
- ROIC
- -8.96%
Growth & Income
- Revenue
- $322.67M · 13.83%
- Net Income
- $-60,513,000 · -41.69%
- EPS
- $-1.97 · -39.72%
- Op Income
- $-91,096,000
- FCF YoY
- -545.09%
Performance & Tape
- 52W High
- $31.04
- 52W Low
- $13.46
- 50D MA
- $15.63
- 200D MA
- $22.03
- Beta
- 0.88
- Avg Volume
- 670.22K
Get TickerSpark's AI analysis on FLGT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Nohaile Michael | other | 5,558 |
| May 14, 26 | Nohaile Michael | other | 8,426 |
| May 14, 26 | Dong Linda | other | 11,117 |
| May 14, 26 | GROVES REGINA E | other | 11,117 |
| Apr 26, 26 | Gao Hanlin | other | 1,645 |
| Apr 26, 26 | Xie Jian | other | 4,361 |
| Apr 26, 26 | Kim Paul | other | 2,747 |
| Mar 9, 26 | Hsieh Ming | other | 750,000 |
| Feb 26, 26 | Xie Jian | other | 1,140 |
| Mar 1, 26 | Xie Jian | other | 1,079 |
Our FLGT Coverage
We haven't published any research on FLGT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FLGT Report →